Table 1 Association of LCN2 expression with the features of Xenograft.

From: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3

Group

LCN2 expression

P value

High

Low

Without Vit D

Control

1

4

 

Cisplatin

5

0

0.048

Vit D applied

Control

0

5

 

Cisplatin

3

2

0.167

Back to article page